M3 (MTHRY) Quality Rank


MTHRY M3 Inc MTHRY
82 GF Score
Price $5.65
GF Value $7.91
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is M3 Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

M3 Quality Rank Related Terms

MTHRY
82GF Score
M3 Inc MTHRY
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is M3 (MTHRY) Overvalued in 2026?

Based on GuruFocus' analysis, M3 stock appears to be undervalued. The current stock price of $5.65 is trading 28.6% below its estimated GF Value™ of $7.91. GuruFocus considers M3 to be Modestly Undervalued.

Key valuation signals for MTHRY:

  • Quality Rank:
  • GF Value™: $7.91 vs. price of $5.65 (28.6% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the MTHRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

M3 Business Description

Other Exchanges 2413:Japan4YC:Germany
Address 1-11-44 Akasaka, Akasaka Intercity, 10th Floor, Minato-ku, Tokyo, JPN, 107-0052
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
82GF Score

Get the complete analysis for MTHRY

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.65
Price
$7.91
GF Value